| Autor: |
Denu RA; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Somaiah N; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: nsomaiah@mdanderson.org. |
| Jazyk: |
angličtina |
| Zdroj: |
The Lancet. Oncology [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. 1105-1107. Date of Electronic Publication: 2024 Aug 07. |
| DOI: |
10.1016/S1470-2045(24)00403-0 |
| Abstrakt: |
Competing Interests: RAD declares no competing interests. NS reports current clinical trial research funding or grant support through the institution from AstraZeneca, Ascentage, Deciphera, Cogent, Boehringer Ingelheim, IDRX, Ningo Newbay, and Bayer, and has been an advisory board consultant (past 2 years) for Adatimmune, Bayer, Deciphera, Ipsen, and Boehringer Ingelheim. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
